Sign in
4

Changes in Ownership

Bone Biologics Corp Filed Acc 0001493152-17-004285

Options or other derivatives

  • CEO and President acquired 538,290 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

La Neve Stephen R. · CEO and President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-05-27 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +538,290 2,653,895 D
Loading xslF345X03/form4.xml…